Brooks Laboratories Limited (BOM:533543)
61.10
-0.46 (-0.75%)
At close: Feb 6, 2026
Brooks Laboratories Revenue
Brooks Laboratories had revenue of 166.91M INR in the quarter ending December 31, 2025, a decrease of -56.59%. This brings the company's revenue in the last twelve months to 893.15M, up 16.05% year-over-year. In the fiscal year ending March 31, 2025, Brooks Laboratories had annual revenue of 825.57M with 3.86% growth.
Revenue (ttm)
893.15M
Revenue Growth
+16.05%
P/S Ratio
2.01
Revenue / Employee
2.77M
Employees
323
Market Cap
1.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 825.57M | 30.71M | 3.86% |
| Mar 31, 2024 | 794.86M | 162.81M | 25.76% |
| Mar 31, 2023 | 632.05M | -279.80M | -30.69% |
| Mar 31, 2022 | 911.85M | 139.38M | 18.04% |
| Mar 31, 2021 | 772.47M | 75.58M | 10.85% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.57B |
| Parnax Lab | 2.05B |
| Ambalal Sarabhai Enterprises | 1.97B |
| Astonea Labs | 1.17B |
| Oxygenta Pharmaceutical | 1.12B |
| Aayush Wellness | 1.11B |
| Quest Laboratories | 1.10B |
| Coral Laboratories | 889.77M |